Search NLS News

Carmo is an expert on injection molding world-wide and a 100 % Danish owned company established in 1940 placed in Espergærde, north of Copenhagen. With a 60-year track record of high-quality injection moulding of highly specialized technical and medical components, they design, produce, and sell quality injection moulded plastic components globally with a significant focus […]

Professor Jan Lundberg has more than 25 years of experience from leading positions in global pharmaceutical companies, including as global head of research at Astra and then AstraZeneca (1996 – 2009) and global head of research and development at Eli Lilly (2010 – 2018). “AlzeCure has a fantastically exciting and promising project portfolio in areas […]

TILT Biotherapeutics has presented preliminary safety and efficacy data from their ongoing Phase I clinical trial in platinum resistant or refractory ovarian cancer patients at the American Association for Cancer Research (AACR) Annual Meeting 2024. “We are excited to see the latest ongoing positive potential to bring a more effective treatment to patients with refractory […]

The US-based private equity firm has committed to acquire Recipharm’s sites in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development in Sweden, Pessac in France, and Parets in Spain. The colleagues at those sites form a new organisation under the leadership of Peter Kruger, Group Managing Director, states Recipharm. “The consolidation of our sites network […]

Within the world of advanced therapy medicinal products (ATMPs), the potential for personalized treatments offers hope for patients worldwide. However, as these therapies evolve, the focus sharpens on their safe transportation. As the industry prepares for a surge in new therapies, distribution challenges are made evident, raising critical questions about efficiency, accessibility, and patient treatment […]

The Novo Nordisk Foundation has awarded a grant of DKK 150 million to establish the Copenhagen Center for Biomedical Quantum Sensing. The centre aims to develop novel quantum sensing principles and techniques for early detection of diseases. It will be located with the Niels Bohr Institute, the physics department at Copenhagen Science City-partner University of […]

Elypta has announced that the interim results from the LEVANTIS-0087A study will be presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego during the Biomarker-Based Screening session on April 9. The population-based case-control study included 2,054 adults over the age of 18 with no symptoms of cancer from the […]

NLS asked the Chief Executive Officer of Sahlgrenska Science Park about her new role and future plans. Congratulations! What are you most looking forward to working with in your new role? “To address healthcare challenges by enabling future lifesaving treatments through healthcare innovation.” You have been the CEO of Cellink and you have held several […]

PostNord TPL has developed an impressive warehousing and distribution facility in Sweden. The warehouse is highly automated and has recently been equipped with an advanced network of humidity and temperature loggers, supplied and installed by the measurement technology company Vaisala. PostNord TPL has developed an impressive warehousing and distribution facility in Sweden, designed specifically to […]

BioInvent International has announced a clinical trial collaboration and supply agreement with MSD International Business for a Phase 1/2a study of its monoclonal antibody BI-1910 in combination with KEYTRUDA. Under the terms of the supply agreement, MSD will provide its anti-PD-1 therapy KEYTRUDA to be used in combination with BI-1910. The Phase 1/2a trial will […]